- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Tsourounis comments on downer drinks
By UCSF School of Pharmacy Editorial Staff / Tue Apr 13, 2010
Candy Tsourounis, PharmD, UCSF School of Pharmacy faculty member and expert on herbal and dietary supplements, comments on consumer products called ”downer drinks” that are purportedly formulated to help people unwind and relax. Tsourounis warns that there is a dearth of research on these products and questions whether the chemicals in these drinks, such as melatonin, are in therapeutic or insignificant—‘fairy dust’—amounts. She also urges that insomnia and the inability to relax might be indicative of other health issues that need to be addressed. The interview appeared April 7, 2010, on AP TV as part of a segment on downer drink products.
Full story
AP: Are Relaxation Drinks Worth It? (Video, 2 minutes, 8 seconds)
Tags
Topics:
Category:
Sites:
School of Pharmacy, Department of Clinical Pharmacy, PharmD Degree Program
Related profiles
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
Related news
- Herbals and dietary supplements: what consumers need to know
- Tsourounis selected to participate in international dietary supplement course
- Know your cholesterol numbers when considering a drug
- Brodowy named director of UCSF Medication Outcomes Center
- PLS chapter wins national leadership challenge grant
